The latest development will provide two purpose-built life sciences buildings over 200,000 sq ft at the campus which aims to become a a global centre for genomics,  biodata, health data and data science.

Nathan Morgan, Project Director & Global Sciences Leader at Gensler, said: “We  are excited to partner with the Wellcome Genome Campus to design the first life sciences buildings in the expansion of its site. This is a significant step forward in  Wellcome Genome Campus realising the vision of a globally significant science  destination, with strong connections to the local environment and community.”

The buildings  will be a gateway to the new campus and feature incubator and accelerator spaces.

Robert Evans, Chief Executive at Wellcome Genome Campus, said: “We are  delighted to gain approval for these striking new buildings, which should start on site  later this year, as part of our Expansion Phase 1.

“We are providing world-class facilities  for translational research and development, supporting growth and enabling new  partnerships and breakthroughs that benefit people everywhere.”